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The National Institute of Health (INSA) has a long tradition in investigating the molecular etiology 
of genetic and complex diseases. These activities greatly benefit from centralized sequencing 
services provided by the Technology and Innovation Unit (UTI). Its mission is to perform 
sequencing and genotyping assays in the framework of research, diagnosis and epidemiological 
surveillance, as well as to implement data analysis pipelines for the study of human gene 
variants. The equipment portfolio includes a NextSeq 550, a MiSeq, two 3500 AB Genetic 
Analyzers, a Fragment Analyzer and a 7500 Real-time PCR system. UTI provides results for 
average of 36.000 sequencing/fragment samples per year. The team has already performed 
>300 small genome, amplicon, gene panel (including clinical exome), 16S rRNA gene and 
RNA/microRNA next-generation sequencing assays for INSA and for several Universities in the 
scope of scientific collaborations. Technical procedures are conducted under a quality control 
system that includes external quality assessment for next-generation sequencing/Sanger 
sequencing and ISO 15189 accreditation for Sanger sequencing. UTI plays a key role in public 
health genomics, providing state-of-the-art equipment, centralized resources, technical 
expertise and short response times. (This work was supported by Centre for Toxicogenomics and 
Human Health - UID/BIM/00009/2019 - and GenomePT project – POCI-01-0145-FEDER-022184) 
